Dr. Jenni Li joins GRACE as guest faculty to provide updated information to our Mandarin Lung Cancer Video Library, for our mandarin speaking community.

In this video, Dr. Li discusses which patients with advanced NSCLC are good candidates for first line immunotherapy alone today.

******

李仁妮博士加入GRACE，担任客座教授，为普通话社区提供最新信息给我们的普通话肺癌视频库。 在此视频中，李医生讨论了哪些晚期NSCLC患者今天仅是一线免疫治疗的好人选。

To join the conversation, visit https://cancergrace.org/forum.

要加入对话，请访问https://cancergrace.org/forum。